BRAF and neoplasm: Although transcriptional profiling distinguishes between PTCs as being ‘RAS-like’ and ‘BRAF-like’ neoplasms with different levels of tumor dedifferentiation and aggressiveness (Cancer Genome Atlas Research Network, 2014), the underlying mechanisms of the morphogenetic traits that give rise to heterogeneous tumor phenotypes in the thyroid are unknown.